{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:52:51Z","timestamp":1792601571648,"version":"4.5.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.pharmthera.2016.01.015","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T02:15:36Z","timestamp":1453688136000},"page":"188-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"special_numbering":"C","title":["Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health"],"prefix":"10.1016","volume":"162","author":[{"given":"Inthrani Raja","family":"Indran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan Lim Zhen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan Ee","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu-Leong","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.01.015_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.32098\/mltj.02.2013.03","article-title":"Cigarette smoking and musculoskeletal disorders","volume":"3","author":"Abate","year":"2013","journal-title":"Muscles Ligaments Tendons J"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0010","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/me.2010-0189","article-title":"Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta\/p66shc signaling cascade: counter regulation by estrogens or androgens","volume":"24","author":"Almeida","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0015","doi-asserted-by":"crossref","first-page":"27285","DOI":"10.1074\/jbc.M702810200","article-title":"Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids","volume":"282","author":"Almeida","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1359\/jbmr.091017","article-title":"Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERalpha","volume":"25","author":"Almeida","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb9020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0030","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2008.193","article-title":"Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women","volume":"74","author":"Boonen","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0040","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1365-2362.2012.02717.x","article-title":"The osteoclast, bone remodelling and treatment of metabolic bone disease","volume":"42","author":"Boyce","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","article-title":"The RANKL\/RANK\/OPG pathway","volume":"5","author":"Boyce","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb9015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0055","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00198-013-2265-1","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate","volume":"24","author":"Cacoub","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/ptr.4840","article-title":"Maohuoside A acts in a BMP-dependent manner during osteogenesis","volume":"27","author":"Cai","year":"2013","journal-title":"Phytother Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb9040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature.2015.18507","article-title":"Anti-parasite drugs sweep Nobel prize in medicine 2015","volume":"526","author":"Callaway","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0060","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women's health initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0065","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha","volume":"106","author":"Cenci","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0080","first-page":"388","article-title":"Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture","volume":"62","author":"Chen","year":"2007","journal-title":"Pharmazie"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/np9601925","article-title":"New prenylflavones from the leaves of Epimedium saggitatum","volume":"59","author":"Chen","year":"1996","journal-title":"J Nat Prod"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1017\/S0007114510003247","article-title":"Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice","volume":"105","author":"Chen","year":"2011","journal-title":"Br J Nutr"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.fct.2013.09.019","article-title":"Salidroside stimulates osteoblast differentiation through BMP signaling pathway","volume":"62","author":"Chen","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2010.03.023","article-title":"Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways","volume":"636","author":"Choi","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-61779-415-5_13","article-title":"RANKL-mediated osteoclast formation from murine RAW 264.7 cells","volume":"816","author":"Collin-Osdoby","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0100","series-title":"Report on Ageing Population","author":"Committee on Ageing Issues","year":"2006"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0105","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a116756","article-title":"Population-based study of survival after osteoporotic fractures","volume":"137","author":"Cooper","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJMoa0808692","article-title":"Lasofoxifene in postmenopausal women with osteoporosis","volume":"362","author":"Cummings","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0115","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMc076132","article-title":"Alendronate and atrial fibrillation","volume":"356","author":"Cummings","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0120","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-010-1302-6","article-title":"Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial","volume":"22","author":"de Villiers","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0125","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/JBMR.050714","article-title":"Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial","volume":"20","author":"Deal","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0130","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/art.21918","article-title":"Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study","volume":"54","author":"Delmas","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0135","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00774-012-0351-7","article-title":"Five-year follow-up study of a kidney-tonifying herbal Fufang for prevention of postmenopausal osteoporosis and fragility fractures","volume":"30","author":"Deng","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0145","first-page":"23","article-title":"Efficacy of ibandronate: a long term confirmation","volume":"7","author":"Di Munno","year":"2010","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jcp.24916","article-title":"Dual effect of cyanidin on RANKL-induced differentiation and fusion of osteoclasts","volume":"231","author":"Dou","year":"2016","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0155","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0160","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men","volume":"106","author":"Falahati-Nini","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0165","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJM199310143291601","article-title":"The effect of postmenopausal estrogen therapy on bone density in elderly women","volume":"329","author":"Felson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12013-013-9533-8","article-title":"Icariin protects against glucocorticoid-induced osteoporosis in vitro and prevents glucocorticoid-induced osteocyte apoptosis in vivo","volume":"67","author":"Feng","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0175","author":"Food and Drug Administration"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0031-9422(88)80627-7","article-title":"Seven prenylated flavonol glycosides from two Epimedium species","volume":"27","author":"Fukai","year":"1988","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0185","doi-asserted-by":"crossref","first-page":"105-105","DOI":"10.1186\/1471-2474-13-105","article-title":"Effect of Epimedium pubescen flavonoid on bone mineral status and bone turnover in male rats chronically exposed to cigarette smoke","volume":"13","author":"Gao","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0195","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/aje\/kwi055","article-title":"Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review","volume":"161","author":"Gennari","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0200","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jchromb.2007.10.045","article-title":"Trace analysis of icariin in human serum with dansyl chloride derivatization after oral administration of Epimedium decoction by liquid chromatography tandem mass spectrometry","volume":"860","author":"Gong","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0190","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10616-014-9694-3","article-title":"Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice","volume":"67","author":"Goto","year":"2015","journal-title":"Cytotechnology"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/PL00004148","article-title":"World-wide projections for hip fracture","volume":"7","author":"Gullberg","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0031-9422(95)00715-6","article-title":"Brevicornin, a flavonol from Epimedium brevicornum","volume":"41","author":"Guo","year":"1996","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0220","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.phymed.2009.08.007","article-title":"Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression","volume":"17","author":"Hsieh","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb9010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.phymed.2010.04.003","article-title":"Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs\/NF-kappaB regulated HIF-1alpha and PGE(2) synthesis","volume":"18","author":"Hsieh","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0225","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.lfs.2007.07.015","article-title":"Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro","volume":"81","author":"Huang","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0230","first-page":"22","article-title":"Selective estrogen receptor modulator effects of Epimedium extracts on breast cancer and uterine growth in nude mice","volume":"80","author":"Indran","year":"2014","journal-title":"Planta Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0235","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2165\/00002018-200932090-00002","article-title":"Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital","volume":"32","author":"Ing-Lorenzini","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0240","first-page":"19","article-title":"Risedronate's efficacy: from randomized clinical trials to real clinical practice","volume":"7","author":"Iolascon","year":"2010","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0245","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1210\/endo.140.4.6663","article-title":"Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency","volume":"140","author":"Ishimi","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb9035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.fct.2007.08.006","article-title":"A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice","volume":"46","author":"Ju","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0250","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.fct.2012.05.017","article-title":"Estrogenic\/antiestrogenic activities of a Epimedium koreanum extract and its major components: in vitro and in vivo studies","volume":"50","author":"Kang","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0255","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","article-title":"Adverse effects of bisphosphonates: implications for osteoporosis management","volume":"84","author":"Kennel","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0265","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/JME-11-0061","article-title":"Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264.7 cells","volume":"48","author":"Kharkwal","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0260","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0270","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1074\/jbc.M109.051557","article-title":"RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis","volume":"285","author":"Kim","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0275","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-2000-8611","article-title":"Flavonol glycosides from Epimedium sagittatum and their neurite outgrowth activity on PC12h cells","volume":"66","author":"Kuroda","year":"2000","journal-title":"Planta Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0770","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00198-010-1177-6","article-title":"Denosumab-related osteonecrosis of the jaws","volume":"22","author":"Kyrgidis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.intimp.2013.03.025","article-title":"Icaritin exhibits anti-inflammatory effects in the mouse peritoneal macrophages and peritonitis model","volume":"16","author":"Lai","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0285","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2147\/CIA.S2046","article-title":"Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women","volume":"3","author":"Lambrinoudaki","year":"2008","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0290","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/en.2004-1021","article-title":"Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation","volume":"146","author":"Lean","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0300","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10616-010-9253-5","article-title":"Inhibitory effect of luteolin on osteoclast differentiation and function","volume":"61","author":"Lee","year":"2009","journal-title":"Cytotechnology"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0305","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","article-title":"A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation","volume":"106","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0310","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1046\/j.1532-5415.2002.50455.x","article-title":"Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study","volume":"50","author":"Leibson","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0315","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1208\/s12248-015-9805-x","article-title":"Marketplace analysis of conjugated estrogens: determining the consistently present steroidal content with LC-MS","volume":"17","author":"Levy","year":"2015","journal-title":"AAPS J"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/DHPS.S7727","article-title":"Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis","volume":"3","author":"Lewiecki","year":"2011","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0325","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2010.07.009","article-title":"Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS\/JNK-dependent mitochondrial pathway","volume":"298","author":"Li","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0320","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/adt.2008.154","article-title":"Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha\/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies","volume":"7","author":"Li","year":"2009","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0345","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/0031-9422(90)80206-V","article-title":"Flavonol glycosides from Epimedium wushanense","volume":"29","author":"Li","year":"1990","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0330","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0031-9422(94)00696-Q","article-title":"Flavonol glycosides from Epimedium koreanum","volume":"38","author":"Li","year":"1995","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0340","first-page":"1461","article-title":"Effects of anhydroicaritin and 2\u2033-hydroxy-3\u2033-en-anhydroicaritin on the proliferation and differentiation of MC3T3-E1 osteoblasts","volume":"7","author":"Li","year":"2012","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0335","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0031-9422(96)00187-2","article-title":"Flavonoids from Epimedium wanshanense","volume":"43","author":"Li","year":"1996","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0350","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-2006-957690","article-title":"Isolation and immunomodulatory effect of flavonol glycosides from Epimedium hunanense","volume":"63","author":"Liang","year":"1997","journal-title":"Planta Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0360","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1530\/ERC-13-0233","article-title":"Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women","volume":"21","author":"Lim","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0365","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bone.2012.03.006","article-title":"Serum free estradiol and estrogen receptor-alpha mediated activity are related to decreased incident hip fractures in older women","volume":"50","author":"Lim","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0385","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10529-014-1661-8","article-title":"A cell-based model of bone remodeling for identifying activity of icarrin in the treatment of osteoporosis","volume":"37","author":"Liu","year":"2015","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0370","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12906-015-0641-4","article-title":"Effects of the combined extracts of Herba epimedii and Fructus ligustri lucidi on bone mineral content and bone turnover in osteoporotic rats","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchromb.2007.10.019","article-title":"Simultaneous determination of icariin, icariside II and osthole in rat plasma after oral administration of the extract of Gushudan (a Chinese compound formulation) by LC-MS\/MS","volume":"860","author":"Liu","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0390","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.phymed.2014.07.016","article-title":"Synergistic inhibitory effect of Icariside II with Icaritin from Herba epimedii on pre-osteoclastic RAW264.7 cell growth","volume":"21","author":"Liu","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0375","first-page":"1076","article-title":"Effect of Herba epimedii flavone on expression of OPG and RANKL in rat osteoblasts","volume":"28","author":"Liu","year":"2005","journal-title":"Zhong Yao Cai"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0380","first-page":"487","article-title":"Effect of Herba epimedii flavone on the osteoblasts metabolism in vitro","volume":"31","author":"Liu","year":"2006","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0395","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1359\/jbmr.1998.13.11.1747","article-title":"Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial","volume":"13","author":"Lufkin","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0400","first-page":"4367","article-title":"Icariside II promotes osteogenic differentiation of bone marrow stromal cells in beagle canine","volume":"8","author":"Luo","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0405","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jep.2011.01.001","article-title":"The genus Epimedium: an ethnopharmacological and phytochemical review","volume":"134","author":"Ma","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0410","doi-asserted-by":"crossref","first-page":"M101","DOI":"10.1093\/geronj\/45.3.M101","article-title":"Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study","volume":"45","author":"Magaziner","year":"1990","journal-title":"J Gerontol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0415","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1185\/030079905X61839","article-title":"Safety assessment of raloxifene over eight years in a clinical trial setting","volume":"21","author":"Martino","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb9025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajhp\/62.1.69","article-title":"Effects of media coverage of Women's Health Initiative study on attitudes and behavior of women receiving hormone replacement therapy","volume":"62","author":"McIntosh","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb9030","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/gme.0b013e318182d367","article-title":"Commentary on black cohosh for the treatment of menopausal symptoms","volume":"15","author":"Mello","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0425","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.phymed.2004.03.007","article-title":"Osteoblastic proliferative activity of Epimedium brevicornum Maxim","volume":"12","author":"Meng","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb9000","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0570","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0031-9422(91)84249-R","article-title":"Ionone and bibenzyl glycosides from Epimedium grandiflorum var. Thunbergianum","volume":"30","author":"Miyase","year":"1991","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0435","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1476-5381.2009.00593.x","article-title":"Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells","volume":"159","author":"Mok","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0440","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00198-009-1097-5","article-title":"Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity","volume":"21","author":"Musette","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0445","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0450","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/mnfr.201400592","article-title":"Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway","volume":"59","author":"Nash","year":"2015","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0455","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0460","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0465","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2009.05.022","article-title":"Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone","volume":"45","author":"Peng","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0470","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bone.2013.02.012","article-title":"The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats","volume":"55","author":"Peng","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0475","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00198-009-1136-2","article-title":"The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review","volume":"21","author":"Peppone","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0480","series-title":"Pharmacopoeia of The People's Republic of China (English Edition)","year":"2010"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0485","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/tcrm.2006.2.3.235","article-title":"Alendronate sodium in the management of osteoporosis","volume":"2","author":"Prinsloo","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0490","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bcp.2003.11.009","article-title":"Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway","volume":"67","author":"Prouillet","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0495","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biomaterials.2015.04.038","article-title":"Phytomolecule icaritin incorporated PLGA\/TCP scaffold for steroid-associated osteonecrosis: proof-of-concept for prevention of hip joint collapse in bipedal emus and mechanistic study in quadrupedal rabbits","volume":"59","author":"Qin","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0505","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/14740338.2014.939169","article-title":"Cardiac concerns associated with strontium ranelate","volume":"13","author":"Reginster","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0500","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","article-title":"Osteoporosis: a still increasing prevalence","volume":"38","author":"Reginster","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0510","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0515","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00223-011-9499-8","article-title":"Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis","volume":"89","author":"Rizzoli","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0520","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1096\/fj.15-272823","article-title":"Estrogen preserves Fas ligand levels by inhibiting microRNA-181a in bone marrow-derived mesenchymal stem cells to maintain bone remodeling balance","volume":"29","author":"Shao","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0525","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.phytochem.2007.03.001","article-title":"Taxonomic, genetic, chemical and estrogenic characteristics of Epimedium species","volume":"68","author":"Shen","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0530","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jchromb.2008.11.030","article-title":"Simple and sensitive liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of five Epimedium prenylflavonoids in rat sera","volume":"877","author":"Shen","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0535","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0540","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1359\/JBMR.050509","article-title":"Skeletal effects of raloxifene after 8years: results from the continuing outcomes relevant to Evista (CORE) study","volume":"20","author":"Siris","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0545","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ptr.4743","article-title":"The effects of an antiosteoporosis herbal formula containing Epimedii herba, Ligustri lucidi fructus and Psoraleae fructus on density and structure of rat long bones under tail-suspension, and its mechanisms of action","volume":"27","author":"Siu","year":"2013","journal-title":"Phytother Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0550","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1074\/jbc.M010764200","article-title":"Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation","volume":"276","author":"Srivastava","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0555","series-title":"The Genus Epimedium and Other Herbaceous Berberidaceae","author":"Stearn W.T","year":"2002"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0560","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1056\/NEJMe068120","article-title":"Risk-benefit profiles of raloxifene for women","volume":"355","author":"Stefanick","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0565","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.phymed.2013.04.019","article-title":"An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis","volume":"20","author":"Sun","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb9045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cmet.2007.05.001","article-title":"Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction","volume":"5","author":"Tatsumi","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0575","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","article-title":"Treatment of postmenopausal osteoporosis with calcitriol or calcium","volume":"326","author":"Tilyard","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0580","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/carcin\/bgs110","article-title":"A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERalpha protein","volume":"33","author":"Tiong","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0585","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0590","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0600","first-page":"3","article-title":"Chemical constituents of Epimedium platyetalum","volume":"44","author":"Wang","year":"2002","journal-title":"Acta Bot Sin"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0610","article-title":"In vivo screening for anti-osteoporotic fraction from extract of herbal formula Xianlinggubao in ovariectomized mice","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0605","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.2147\/DDDT.S89505","article-title":"Bu-Shen-Ning-Xin Decoction ameliorated the osteoporotic phenotype of ovariectomized mice without affecting the serum estrogen concentration or uterus","volume":"9","author":"Wang","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0615","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bcp.2014.03.020","article-title":"Isoquercitrin and polyphosphate co-enhance mineralization of human osteoblast-like SaOS-2 cells via separate activation of two RUNX2 cofactors AFT6 and Ets1","volume":"89","author":"Wang","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0595","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.phytochem.2007.05.035","article-title":"Prenylflavonol, acylated flavonol glycosides and related compounds from Epimedium sagittatum","volume":"68","author":"Wang","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0620","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0006-2952(02)01445-4","article-title":"Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption","volume":"65","author":"Wattel","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0625","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","article-title":"Estrogen deficiency and bone loss: an inflammatory tale","volume":"116","author":"Weitzmann","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0635","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1142\/S0192415X1450027X","article-title":"Er-Xian decoction exerts estrogen-like osteoprotective effects in vivo and in vitro","volume":"42","author":"Wong","year":"2014","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0640","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/adt.2007.056","article-title":"Ultrasensitive cell-based bioassay for the measurement of global estrogenic activity of flavonoid mixtures revealing additive, restrictive, and enhanced actions in binary and higher order combinations","volume":"5","author":"Wong","year":"2007","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0645","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jpba.2009.04.022","article-title":"Pharmacokinetics of prenylflavonoids and correlations with the dynamics of estrogen action in sera following ingestion of a standardized Epimedium extract","volume":"50","author":"Wong","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0650","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMc0808738","article-title":"Reports of esophageal cancer with oral bisphosphonate use","volume":"360","author":"Wysowski","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0655","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/j.msec.2013.04.050","article-title":"Icariin delivery porous PHBV scaffolds for promoting osteoblast expansion in vitro","volume":"33","author":"Xia","year":"2013","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0660","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/13880209.2012.738332","article-title":"Icariin delays homocysteine-induced endothelial cellular senescence involving activation of the PI3K\/AKT-eNOS signaling pathway","volume":"51","author":"Xiao","year":"2013","journal-title":"Pharm Biol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0665","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jsbmb.2014.02.019","article-title":"Flavonoids from Herba epimedii selectively activate estrogen receptor alpha (ERalpha) and stimulate ER-dependent osteoblastic functions in UMR-106 cells","volume":"143","author":"Xiao","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0670","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/14786410701369680","article-title":"Chemical constituents of roots of Epimedium wushanense and evaluation of their biological activities","volume":"21","author":"Xie","year":"2007","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0675","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ecam\/neh101","article-title":"The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro","volume":"2","author":"Xie","year":"2005","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0680","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1757-7861.2011.00129.x","article-title":"Dynamic expression of DKK1 protein in the process whereby Epimedium-derived flavonoids up-regulate osteogenic and down-regulate adipogenic differentiation of bone marrow stromal cells in ovariectomized rats","volume":"3","author":"Xu","year":"2011","journal-title":"Orthop Surg"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0685","doi-asserted-by":"crossref","first-page":"241416","DOI":"10.1155\/2012\/241416","article-title":"Comparative effects of Er-Xian decoction, Epimedium herbs, and icariin with estrogen on bone and reproductive tissue in ovariectomized rats","volume":"2012","author":"Xue","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0690","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10495-013-0867-x","article-title":"Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway","volume":"18","author":"Yang","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0700","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jep.2011.03.056","article-title":"Antiosteoporotic compounds from seeds of Cuscuta chinensis","volume":"135","author":"Yang","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041264","article-title":"Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis\u2014an in vitro efficacy study","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0705","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2005-837776","article-title":"New estrogenic prenylflavone from Epimedium brevicornum inhibits the growth of breast cancer cells","volume":"71","author":"Yap","year":"2005","journal-title":"Planta Med"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0710","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jep.2007.05.029","article-title":"Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb, Epimedium","volume":"113","author":"Yap","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0715","series-title":"Herbal and Traditional Medicine: Biomolecular and Clinical Aspects","first-page":"60","article-title":"Herbal Medicine","author":"Yong","year":"2004"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0720","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02489575","article-title":"Anthocyanins and their distribution in the genus Epimedium","volume":"97","author":"Yoshitama","year":"1984","journal-title":"Bot Mag Tokyo"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0735","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.phymed.2007.04.002","article-title":"Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts","volume":"15","author":"Zhang","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0745","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1742-7843.2010.00595.x","article-title":"Icariin inhibits hydrogen peroxide-mediated cytotoxicity by up-regulating sirtuin type 1-dependent catalase and peroxiredoxin","volume":"107","author":"Zhang","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0740","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1359\/jbmr.070405","article-title":"Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial","volume":"22","author":"Zhang","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0725","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jep.2005.01.033","article-title":"In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms","volume":"98","author":"Zhang","year":"2005","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0750","article-title":"Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0730","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.biochi.2012.06.033","article-title":"Herba epimedii flavonoids suppress osteoclastic differentiation and bone resorption by inducing G2\/M arrest and apoptosis","volume":"94","author":"Zhang","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0755","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-015-2452-9","article-title":"Apigenin promotes osteogenic differentiation of human mesenchymal stem cells through JNK and p38 MAPK pathways","volume":"407","author":"Zhang","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0760","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0b013e31827cd3dd","article-title":"A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women","volume":"20","author":"Zhong","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.pharmthera.2016.01.015_bb0765","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00198-011-1577-2","article-title":"The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis","volume":"23","author":"Zhu","year":"2011","journal-title":"Osteoporos Int"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T19:20:14Z","timestamp":1718306414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":160,"alternative-id":["S0163725816000164"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.01.015","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}